NCT06638515

Brief Summary

The aim of this randomized controlled study is to explore the hypoalgesic response of a 6 minutes of intermittent walking apneas training session at low lung volume in healthy subjects; also, as secondary objectives, to analyze the cardiovascular and respiratory response produced during the intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

October 9, 2024

Last Update Submit

October 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain pressure threshold (PPT) on thumb, anterior tibial and spinous process of C7

    PPT is tested on the dorsal base of the distal phalanx of the thumb on the dominant side and on the muscle belly of the tibialis anterior on the dominant side. The region to be pressed is marked with a pen. The patient is instructed to report with the first appearance of the sensation of "discomfort". An ascending ramp of 0.5 kg/cm/s is applied, at the rhythm of a metronome. The measurement is started on the thumb, and alternated with tibia and C7 until 3 measurements of each region are obtained, enough time to give 30 seconds of rest between measurements in the same region. This protocol has demonstrated high inter-observer reliability measuring healthy subjects (ICC = 0.91).

    before and after intervention (up 30 minutes)

Secondary Outcomes (7)

  • Perceived Stress Scale (PSS)

    before intervention (up 5 minutes)

  • Pittsburg Sleep Quality Index (PSQI)

    before intervention (up 5 minutes)

  • Global Physical Activity Questionnaire (GPAQ)

    before intervention (up 5 minutes)

  • Oxygen saturation

    during intervention (up 6 minutes)

  • Blood pressure

    before and after intervention (up 10 minutes)

  • +2 more secondary outcomes

Study Arms (2)

Walking apnea at Low Lung Volume

EXPERIMENTAL

Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes performing series of intermitent apneas

Other: Walking apnea at Low Lung Volume

Walking normal breathing

ACTIVE COMPARATOR

Participants walk with normal breathing at 6 km/h (10% slope) on treadmill for 6 minutes.

Other: Walking at normal breathing

Interventions

Walking apnea at low Lung Volume Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the experimental group will perform intermittent apneas at high lung volume with a density of 5 seconds, followed by a normal breath of 5 seconds until completing the 6 minutes)

Walking apnea at Low Lung Volume

Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the control group will remain breathing normally for these 6 minutes.

Walking normal breathing

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Asymptomatic subjects aged between 18 and 64 years.

You may not qualify if:

  • Cardiovascular, respiratory, metabolic, neurological or osteomuscular signs or pathologies.
  • History of epilepsy.
  • Pregnant
  • Pharmacological treatment.
  • Participants who present any type of pain on the day of the measurements or who have frequently suffered pain during the previous 4 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CSEU LaSalle

Madrid, Spain

RECRUITING

MeSH Terms

Conditions

PainHypoxiaHypercapniaApnea

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratoryRespiration DisordersRespiratory Tract Diseases

Central Study Contacts

Francisco de Asís Fernandez

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Profesor / Investigador

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

November 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations